Download

http://www.docstoc.com/docs/2141276/WyethLtd-InvestmentIdea271008

Wyeth Limited, a 57.12% subsidiary of Wyeth Inc.,USA has put decent result for Q2 FY 2009. Net
Sales rose by 20.9% to Rs. 105.4 crore (Rs. 87.23 crore) led by 22.9% increase in Pharma sales of Rs. 95.79
crore. Other business (OTC pharma, cosmetics and allied consumer products) turnover was up by 7.8% to Rs
10.12 crore. However, OPM% declined to 40.8% (41.6%) due to 45% spurt in personnel cost to 8.92% of sales
(7.46%) and 34% rise in other expenditures to 20.67% (18.58%) of sales. In nut shell, PBT grew @ 20% to Rs.
46.69 crore. Lower average tax rate of 27.3% (29.6%) boosted PAT up by 25% to 33.83 crore (Rs. 27.05 crore).

Related articles by Zemanta

• Big Pharma Goes Before Supreme Court To Get State Lawsuits Banned [Wyeth]
• Jury hits Wyeth with $134.5M in damages